<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Subjects:

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Subjects:

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

ESR estimates of the average treatment effect for female decision makers. by Nancy Ndung’u (21601567)

ESR estimates of the average treatment effect male decision makers. by Nancy Ndung’u (21601567)

Survival curve of ART Treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Differences in immune infiltration between NAFLD and control groups. by Jiyong Zhang (2498740)

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

Survival function analysis of mortality for Viral load status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of treatment Interruption for Viral load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of viral suppression for BMI status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Baseline characteristics of the participants. by Jia Song (495396)

“…In the initial stage of treatment, the patient’s estimated glomerular filtration rate (eGFR) level decreased and serum potassium level increased compared to before, but with prolongation of the treatment time, both eGFR and serum potassium levels remained stable.…”

Estimated cumulative hazard against Cox-Snell residuals for the Exponential, Gompertz, Weibull and Lognormal models. by Farayi Kaseke (19560197)

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Kaplan-Meier survivor estimates by functional outcome, age group, hospital bill payment and housing status. by Farayi Kaseke (19560197)